Active Ingredient: Bortezomib Dosage: 2mg Form: Lyophilized Powder (for Injection) Usage: Used for the treatment of Multiple Myeloma and Mantle Cell Lymphoma (types of cancer). Administration: Given only through Intravenous (IV) Bolus Injection. Prescription Requirement: Available only with a prescription from an Oncologist (Cancer Specialist Doctor).